Claims for Patent: 4,994,370

Summary for Patent: 4,994,370

Title:	DNA amplification technique
Abstract:	A modification of the polymerase chain reaction (PCR) technique is described. The method allows the amplification of regions of DNA flanking a single region of known sequence, in contrast to standard PCR which requires two regions of known sequence at opposite ends of the fragment to be amplified. Various advantages of the new method are described.
Inventor(s):	Silver; Jonathan (Bethesda, MD), Keerikatte; Vijaya R. (Bethesda, MD)
Assignee:	The United States of America as represented by the Department of Health (Washington, DC)
Application Number:	07/292,814
Patent Claims:	1. A method of amplifying double-stranded DNA sequences extending to one or both sides of a single region of known sequence, comprising the steps of: (a) cutting double-stranded DNA into fragments with a least one restriction enzyme, wherein at least one restriction fragment comprises a region of known sequence and a flanking DNA sequence to be amplified; (b) circularizing said at least one fragment obtained in step (a) with a DNA ligase; (c) hybridizing said circularized fragment with two oligonucleotide primers complementary to opposite strands of said region of known sequence, wherein said primers are oriented with their 5' ends toward one another; and (d) performing a polymerase chain reaction, wherein 5' to 3' primer extension proceeds from each oligonucleotide primer around the circularized fragment. 2. The method of claim 1, wherein said at least one restriction enzyme generates junction fragments with cohesive ends. 3. The method of claim 2, wherein said restriction enzyme is selected from the group consisting of Sau3A, NlaIII, and HhaI. 4. The method of claim 1, further comprising inactivating the restriction enzyme prior to step (b). 5. The method of claim 1, further comprising inactivating the ligase after step (b). 6. The method of claim 1, further comprising linearizing said circularized fragment prior to step (d) by adding a restriction enzyme reactive only in the region of known sequence, wherein said restriction enzyme cuts between regions corresponding to the 5' ends of said two oligonucleotide primers. 7. The method of claim 1 further comprising nicking one strand of said circularized DNA prior to step (d). 8. The method of claim 7, wherein said nicking is performed by heating or digesting with DNAse I in the presence of ethidium bromide. 9. The method of claim 1, wherein said region of known sequence is an insertion element and said flanking DNA sequence to be amplified is an integration site for said insertion element and flanking regions thereof. 10. The method of claim 9, wherein said insertion element is a proviral insertion element. 11. The method of claim 10, wherein said proviral insertion element is a retroviral insertion element. 12. The method of claim 1, wherein said region of known sequence is a region of a transcribed gene or cDNA thereof and said flanking DNA sequence to be amplified is from control regions upstream or downstream from said known sequence. 13. The method of claim 1, wherein said region of known sequence is an exon or partial sequence thereof and said flanking DNA sequence to be amplified is an adjacent intron. 14. The method of claim 1, wherein said region of known sequence is an intron boundary and said flanking DNA sequence to be amplified is an adjacent exon. 15. The method of claim 14, wherein said exon is from a patient suspected of containing a mutation or genetic defect. 16. A method of amplifying DNA sequences extending to one side of a single region of known sequence comprising the steps of: (a) generating a double-stranded DNA fragment with a restriction enzyme, wherein said restriction enzyme cuts in a region of known sequence and in flanking DNA extending to one side of said known sequence; (b) melting the DNA fragment generated in step (a) to produce single-stranded fragments; (c) contacting a selected single-stranded fragment from step (b) with an oligonucleotide, said oligonucleotide having portions complementary to the 5' and 3' ends of said single-stranded fragment, wherein a first portion of said oligonucleotide is complementary to said region of known sequence located at the 5' or 3' end of said fragment and a second portion of said oligonucleotide is complementary to at least a portion of said flanking DNA located at an end of said single-stranded fragment opposite said region of known sequence; (d) ligating the 5' and 3' ends of said single-stranded fragment brought into juxtaposition by hybridization to said oligonucleotide to form a circularized single-stranded DNA template; (e) generating a DNA strand complementary to said circularized template of step (d) through 5' to 3' extension of a first oligonucleotide primer corresponding to a first portion of said region of known sequence; and (f) performing a polymerase chain reaction using said oligonucleotide primer of step (e) and a second oligonucleotide primer corresponding to a second portion of said region of known sequence, wherein said second oligonucleotide primer is complementary to said strand generated in step (e), and primer extension proceeds from each oligonucleotide primer through said flanking DNA to the other oligonucleotide primer.

Details for Patent 4,994,370

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26